Novartis digs deeper into cancer with up to $750 mln Aduro deal -- Reuters

Swiss drugmaker Novartis is digging deeper into the world of cancer immunotherapy - one of the hottest areas of drug research - through a tie-up with California-based Aduro Biotech worth up to $750 million, Reuters News reported.

North AmericaUSBriefs